Cell-Based Flu Antigen to Be Incorporated in DelSite's Nasal Vaccine Product DelSite is developing a nasal powder vaccine for pandemic avian influenza that combines its proprietary GelVac(TM) vaccine ...
AI-driven research has produced nasal antivirals that block flu and Covid before cell infection, pointing to new prevention ...
LONDON--(BUSINESS WIRE)--The global nasal implants market is expected to post a CAGR of close to 6% during the period 2019-2023, according to the latest market research report by Technavio. The ...
Product development activities for SPL7013, repurposed as an antiviral nasal spray, are now well advanced with formulations developed, a manufacturer selected and pilot manufacture undertaken ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback